TRADE WITH CONVICTION

Sunday, May 17, 2026
RSS


← All Stories

Earnings
VRTX: Is Vertex Pharmaceuticals a Safe Haven in a Turbulent Market?

Vertex's 4% surge on kidney drug trial results highlights why long-term investors are finding shelter in this biotech gi…

Catherine Walsh • Mar 12, 2026
Earnings
Oracle's AI Gambit Pays Off: Is ORCL a Must-Have Stock for the Long-Term Investor?

Oracle's Q3 earnings crush expectations, proving its cloud-AI pivot is more than just smoke and mirrors. Here's why $ORC…

Marcus Rivera • Mar 12, 2026
Earnings
Oracle's Cloud Crusade Faces the Volatility Guillotine

As $ORCL prepares to report Q3 earnings, the database giant must prove its cloud pivot can deliver growth amid tech sect…

Marcus Rivera • Mar 10, 2026
Earnings
Casey's General Stores: Can the 27% Growth Story Hold Up Against Economic Reality?

While CASY eyes 27% earnings growth, investors should weigh inflation risks and margin pressures before Monday's report.

Diana Kowalski • Mar 10, 2026
Earnings
Casey's Q3 Preview: Strong Growth Expected, But Can the Midwest Chain Weather the Storm?

Casey's ($CASY) faces sky-high expectations with 27% projected EPS growth ahead of March 9 earnings, but regional risks …

Diana Kowalski • Mar 10, 2026
Earnings
Casey's Q3 Earnings Preview: Strong Growth Projections Hide Potential Headwinds

While CASY expects 27% earnings growth, investors should weigh convenience sector risks against optimistic forecasts.

Diana Kowalski • Mar 10, 2026
Earnings
Casey's General Stores: 27% Earnings Growth Looks Impressive, But Hidden Risks Lurk

While Casey's ($CASY) targets 27% Q3 earnings growth, investors should examine margin pressures and competitive threats …

Diana Kowalski • Mar 10, 2026
Earnings
Casey's $2.97 EPS Target Looks Rosy, But Valuation Risks Linger Ahead of Q3

Casey's General Stores ($CASY) expects 27% Q3 earnings growth, but investors should note risks from high valuation and f…

Diana Kowalski • Mar 10, 2026